InvestorsHub Logo
Followers 58
Posts 10044
Boards Moderated 1
Alias Born 09/21/2016

Re: XenaLives post# 157963

Monday, 07/16/2018 8:05:21 AM

Monday, July 16, 2018 8:05:21 AM

Post# of 458503

I find her totally credible



Agree, she does present a fact based and honest story. It all makes sense. BP treats/sells about/around symptoms.(see greenfields) Having spent a lot of time in the field I know what the priorities are for the people who produce this stuff.

If we accept this premise then what can be done to ensure the upcoming AAIC is not sold to the highest bidder? CNS diseases must be at the top of the pile for BP cash sources. Can we assume that all BP (except BIIB) dropping the Amyloid thesis is a message that they and FDA...finally GET IT? I am not there yet and assume BIIB w/established interest will do whatever they can to control the agenda at AAIC and the take-aways. IMO-The last thing they want is Precision Medicine.

Will AVXL have an effective plan and execution?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News